Skip to main content
Journal of Pediatric Oncology Nursing logoLink to Journal of Pediatric Oncology Nursing
. 2021 Mar 9;38(4):254–261. doi: 10.1177/1043454221992321

Associations of Age, Gender, and Family Income with Quality of Life in Children With Advanced Cancer

Piera C Robson 1,, Mary S Dietrich 1,2, Terrah Foster Akard 1
PMCID: PMC8822186  PMID: 33686901

Abstract

Background: Children with cancer often experience decreased quality of life (QOL) throughout the illness trajectory. The purpose of this study was to explore the associations of demographic characteristics with QOL in children with advanced cancer. Methods: This secondary analysis was part of a larger randomized clinical trial that evaluated the efficacy of a legacy intervention for children (7–17 years) with relapsed/refractory cancer and their primary parent caregivers. Assessments included child self-reports on the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Researchers used descriptive and linear regression statistical methods. Results: Children (n = 128) averaged 10.9 years (SD = 3.0). The majority were female (n = 68, 53%), white (n = 107, 84%), had a hematologic malignancy (n = 67, 52%), with family incomes of $50,000 or less (n = 81, 63.3%). Statistically significant positive associations of both age and income level with PedsQL scores were observed (p < .05) but not gender (p > .05). The strongest correlations for age were with the procedural anxiety (beta = 0.42), treatment anxiety (beta = 0.26), and total (beta = 0.28) scores (all p < .01). In general, there was a positive correlation between family income levels and PedsQL scores (p < .05). The strongest correlations for income were with nausea (R = 0.49), appearance (R = 0.44), pain, and treatment anxiety (both R = 0.42) (all p < .01). Associations adjusted for age remained essentially the same (all p < .01). Discussion: Children with advanced cancer with lower family income and younger age are at high risk for poorer QOL. Oncology nurses should seek to identify families who may benefit from additional resources to promote QOL.

Keywords: quality of life, pediatric cancer, advanced cancer, family income

Introduction

Children with cancer experience substantial suffering and decreased quality of life (QOL) throughout their illness trajectory (Dupuis et al., 2016; Eiser et al., 2017; McCullough et al., 2018; Rae et al., 2018; Rosenberg et al., 2016; Smith et al., 2013; Wolfe et al., 2015). Patient reported outcome measures (PROMs), including QOL assessment, offer clinicians insight into the patient's experience and symptoms and potentially improve communication between the patient and provider (Avoine-Blondin et al., 2018; Howell et al., 2015). The child self-report of QOL has been found to be reliable and valid and give children older than 5 years a voice through the use of age-appropriate measures (Varni et al., 2005, 2007).

The QOL of children with advanced cancer has not been extensively evaluated. To better understand the current knowledge on pediatric QOL in advanced cancer, a PubMed query was conducted. The terms advanced/relapsed/refractory cancer, QOL, and pediatric/child in the title or abstract yielded 38 results, of which 10 evaluated QOL in children with advanced cancer. Most of the publications describe the outcomes of the PediQUEST study (Bilodeau et al., 2019; Ilowite et al., 2018; Rosenberg et al., 2016; Ullrich et al., 2018; Wolfe et al., 2014, 2015). This was a multisite, prospective, longitudinal study at three urban, academic medical centers evaluating symptom distress and QOL in children with advanced cancer who were >2 years of age. The central findings of the PediQUEST study were that cancer symptoms, such as pain, sadness, fatigue, vomiting, and anorexia were associated with distress and lower QOL in children with advanced cancer (Rosenberg et al., 2016; Ullrich et al., 2018; Wolfe et al., 2014, 2015).

Few studies on pediatric cancer patients have explored the associations between QOL and demographic characteristics such as age, sex, and income. Two studies found that children under 5 years of age with acute lymphocytic leukemia (ALL) experienced greater treatment and procedural anxiety, which are dimensions of QOL assessment (Dupuis et al., 2016; Sitaresmi et al., 2008). However, this association between age and QOL was not found in the PediQUEST study (Rosenberg et al., 2016). Associations between gender and QOL have not been identified in children with cancer (Dupuis et al., 2016; Rosenberg et al., 2016; Sitaresmi et al., 2008).

Where the impact of socioeconomic status on adult cancer patients has been well described (Abel et al., 2016; Bilodeau et al., 2018; Bona et al., 2015; Macpherson et al., 2020; Santacroce & Kneipp, 2019), the association of a family's current financial situation on QOL in children with cancer has not been extensively explored. As part of the PediQUEST study, researchers explored associations of family income with QOL and symptoms in children with advanced cancer. They found that children whose families were in the low-income group (<$50,000) had poorer total QOL than those in the high-income group (Ilowite et al., 2018). Common cancer symptoms such as fatigue, pain, and nausea were more prevalent in the lower financial brackets; however, only pain demonstrated a statistically significant difference (p = .02). This direct association with income and QOL was not replicated with those with ALL (Dupuis et al., 2016; Sitaresmi et al., 2008).

To improve QOL in pediatric oncology patients, there is a need to understand the demographic characteristics associated with poorer QOL for all cancer diagnoses so that interventions can be targeted to those who are most likely to benefit. The purpose of this study was to explore the associations of child demographic characteristics (age, gender, family income) with QOL in children with advanced cancer.

Methods

This study was a secondary analysis of data from an Institutional Review Board (140622, Vanderbilt University) approved randomized clinical trial (RCT) that evaluated the efficacy of a web-based legacy intervention for children with advanced cancer and their parents (Akard et al., 2020). Legacy making has been defined as actions or behaviors aimed at being remembered (Akard et al., 2015, 2018, 2020). Complete details of the RCT are reported elsewhere (Akard et al., 2020). In brief, eligible children and their primary parent caregivers were recruited via Facebook advertisements (Akard et al., 2020). Children were aged 7–17 years without cognitive impairment, of any gender, with relapsed or refractory cancer (based on parent self-report) and living in the United States. Participants spoke and understood English and had internet access. Children and their primary parent caregivers provided verbal consent and assent. Families received up to $275 as a thank you for participating in the study. The IRB waived the requirement for written consent. Child–parent dyads were randomized 1:1 to the intervention or usual care group. Parents reported child demographic information via an electronic survey.

Investigators collected and managed data using Research Electronic Data Capture (REDCap), a secure, web-based software platform designed to support data capture for research studies, providing (1) an intuitive interface for validated data capture; (2) audit trails for tracking data manipulation and export procedures; (3) automated export procedures for seamless data downloads to common statistical packages; and (4) procedures for data integration and interoperability with external sources (Harris et al., 2019, 2009). Child and parent participants completed electronic measures for psychosocial outcomes (QOL, coping, child–parent communication) via REDCap at baseline/pre- (T1) and post-intervention (T2). This secondary analysis included child demographic and clinical characteristics and child QOL outcomes collected at the baseline time of assessment in the primary study. Participants were excluded from this study if QOL or family income data were missing. Since demographic characteristics were only collected at baseline, this study was limited to a cross-sectional evaluation at the time of enrollment.

Parents reported child demographic and clinical characteristics (noted in Table 1) on a demographic survey. Children self-reported their QOL on the 27-item Pediatric Quality of Life Inventory (PedsQL) Cancer Module 3.0. The instrument provides a total score and dimension scores for pain and hurt, nausea, procedural anxiety, treatment anxiety, worry, cognitive problems, perceived physical appearance, and communication (Varni et al., 2002). The young child (5-7), children (8-12), and teens (13-18) self-report scales were used (Varni et al., 2002). The original Likert responses (0-4) were recoded to a possible range of 0-100 and reversed so that higher scores represent better QOL. The dimension and total scores were generated by calculating the mean of the recorded respective component items (Varni, 2017). Internal consistency of the child report total and dimension scores in this study ranged from 0.84 (perceived appearance) to 0.96 (both procedural and treatment anxiety).

Table 1.

Descriptive Summary of Sample Demographic and Clinical Characteristics (N = 128).

Characteristic Mean (SD)
Age 10.9 (3.0)
N (%)
Child sex
 Male 60 (46.9%)
 Female 68 (53.1%)
Race (N = 126)
 White 107 (84.9%)
 Black or African American 4 (3.2%)
 Asian 2 (1.6%)
 American Indian or Alaska Native 2 (1.6%)
 Other 11 (8.7%)
Ethnicity (N = 126)
 Hispanic or Latino 15 (11.9%)
 Not Hispanic or Latino 111 (88.1%)
Primary language
 English 124 (96.9%)
 Spanish 4 (3.1%)
Location of permanent home
 Northeast 17 (13.3%)
 Southeast 29 (22.7%)
 Midwest 66 (51.6%)
 Southwest 11 (8.6%)
 West 5 (3.9%)
Current family income per year
 Under $25,000 50 (39.1%)
 $25,001–$50,000 31 (24.2%)
 $50,001–$75,000 16 (12.5%)
 $75,001–$100,000 15 (11.7%)
 $100,001 or more 16 (12.5%)
Malignancy type
 Hematologic 67 (52.3%)
 Solid tumor 34 (26.6%)
 CNS tumor 27 (21.1%)
History of:
 Cancer relapse or recurrence 88 (68.8%)
 Secondary cancer (N = 127) 3 (2.4%)
 Surgery to remove a tumor 53 (41.4%)
 Chemotherapy treatments 121 (94.5%)
 Radiation therapy 85 (66.4%)
 Bone marrow transplant 22 (17.3%)
Phase 1 clinical research involvement
 Yes 22 (17.2%)
 No 78 (60.9%)
 Unsure 28 (21.9%)
Been told cancer is terminal 13 (10.2%)
Presence of active DNR order 2 (1.6%)
Currently enrolled in hospice
 Yes 2 (1.6%)
 No 125 (97.7%)
 Unknown 1 (0.8%)
Currently enrolled in palliative care
 Yes 7 (5.5%)
 No 115 (89.8%)
 Unknown 6 (4.7%)
Median (IQR)
Years since diagnosis (N = 127) 3.9 (1.8, 6.0)

Note. DNR: Do not resuscitate.

Analysis

IBM SPSS Statistics (version 26) was used for analyzing the data. The sample demographic, clinical, and PedsQL score distributions were summarized and evaluated using descriptive statistics. Linear regression models were used to generate the unadjusted associations of child sex, child age, and family income level with each of the PedsQL scores, as well as the adjusted associations of income level controlling for child age. Age was measured on a continuous scale; therefore the standardized regression coefficient (beta) serves as an indicator of the strength of the association of that variable with each of the PedsQL scores. Income was assessed as ordinal categories, thus the association of income with each of the PedsQL scores was assessed by the multiple correlation (R) of the categories as a set of variables with each score. The adjusted multiple correlations of income with the PedsQL scores reflect those same correlations after controlling for the correlations of age with each of those respective scores (middle column). For statistical significance, an alpha of 0.05 was used (p < .05).

Results

The sample included 128 children for analysis. Demographic and clinical characteristics are summarized in Table 1. Child participants averaged 10.9 years (SD 3.0). There were slightly more female children than male, most were white with a hematologic malignancy and reported their primary language to be English. The majority of respondents lived in the Midwest region of the United States with a family income of $50,000 or less (n = 81, 63.3%); 39.1% (n = 31) had an income of $25,000 or less per year. The children were approximately 4 years (median) since initial diagnosis; a majority had suffered a relapse or recurrence but were not receiving palliative care or hospice services (see Table 1). Of the demographic characteristics of interest (age, race/ethnicity, primary language, and income), the sample was too small to include the relatively homogeneous characteristics of race/ethnicity and primary language (85% white, 88% non-Hispanic). Thus, only the characteristics of age, child sex, and family income were included in the analyses of associations with the PedsQL scores.

The children's PedsQL scores are summarized in Table 2. As shown, the median values tended to be toward the middle of the possible range of scores with considerable variability in the scores. No statistically significant or meaningful associations of child gender with PedsQL scores were observed (beta = 0.01–0.13, p > .10). Associations of child age and family income level with each of the PedsQL scores are shown in Table 2. Age had statistically significant positive associations with the PedsQL total score and specifically with the procedural anxiety, treatment anxiety, communication, pain, and nausea dimension scores demonstrating that as age increased PedsQL scores tended to increase also. Family income level was statistically significantly positively associated with all of the PedsQL scores demonstrating that as income levels increased, PedsQL scores also tended to increase (all p < .01). The strongest correlations with the specific PedsQL dimensions were demonstrated for nausea, appearance, pain, and treatment anxiety (see Table 2).

Table 2.

Descriptive Summaries of the Pediatric Quality of Life Inventory (PedsQL) Scores and Associations of Age and Income Level With Those Scores (N = 128) a .

Child age Family income level
PedsQL score Median (IQR) r (p-value) R (p-value)
Total 49.5 (24.4, 67.7) 0.28 (.002) 0.48 (<.001)
Pain (N = 127) 37.5 (12.5, 62.5) 0.20 (.024) 0.42 (<.001)
Nausea 45.0 (20.0, 70.0) 0.20 (.022) 0.49 (<.001)
Procedural anxiety 41.7 (0.0, 66.7) 0.42 (<.001) 0.36 (.002)
Treatment anxiety 50.0 (25.0, 83.3) 0.26 (.003) 0.42 (<.001)
Worry 41.7 (16.6, 66.7) 0.11 (.226) 0.32 (.009)
Cognitive problems 45.0 (25.0, 65.0) 0.17 (.051) 0.36 (.002)
Appearance 64.6 (25.0, 83.3) 0.17 (.059) 0.44 (<.001)
Communications 58.3 (25.0, 83.3) 0.24 (.007) 0.39 (<.001)
a

Age was measured on a continuous scale therefore the Pearson correlation coefficient was used to assess those correlations with the PedsQL scores. Income was measured as ordinal categories thus the association of income with each of the PedsQL scores was assessed by the multiple correlation (R) of the categories as a set of variables with each score.

Detailed summaries of the multivariate associations of age and income with the PedsQL scores are shown in Table 3. All of those multivariate associations with the scores were statistically significant (multiple R > 0.30, p < .02, Table 3). After controlling for the effects of family income, age remained statistically significantly positively associated with the PedsQL total score (beta = 0.19, p = .020) however specifically, with only the two anxiety dimensions (procedural: beta = 0.36, p < .001; treatment: beta = 0.18, p = .030). After controlling for the effects of age, family income level remained statistically significantly positively associated with all of the PedsQL scores (adjusted R > 0.27, p < .02, Table 3). As is apparent from the patterns of the beta coefficients for each of the increasing income levels (compared to <$25,000), there was a generally increasing positive effect of income on the QL scores with each increase in family income level (see Table 3).

Table 3.

Multivariate Associations of Age and Income with Pediatric Quality of Life Inventory (PedsQL) Total and Domain Scores.

Characteristic PedsQL score
Total Pain Nausea Procedural anxiety Treatment anxiety Worry Cognitive problems Appearance Communications
Model multiple R (p-value) 0.51 (<.001) 0.44 (<.001) 0.51 (<.001) 0.50 (<.001) 0.46 (<.001) 0.32 (.018) 0.38 (.002) 0.45 (<.001) 0.42 (<.001)
beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value)
Age 0.19 (.020) 0.13 (.127) 0.13 (.107) 0.36 (<.001) 0.18 (.030) 0.04 (.661) 0.11 (.194) 0.07 (.388) 0.17 (.051)
Income adjusted R (p-value) 0.43 (<.001) 0.39 (<.001) 0.46 (<.001) 0.28 (.018) 0.38 (<.001) 0.30 (.016) 0.34 (.004) 0.42 (<.001) 0.35 (.002)
a <$25,000 beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value) beta (p-value)
$25-50,000 0.21 (.016) 0.14 (.133) 0.24 (.007) 0.14 (.120) 0.16 (.088) 0.21 (.031) 0.21 (.028) 0.26 (.006) 0.06 (.549)
$50-75,000 0.28 (.002) 0.23 (.014) 0.15 (.078) 0.18 (.037) 0.26 (.005) 0.21 (.030) 0.14 (.135) 0.31 (.001) 0.30 (.001)
$75-100,000 0.39 (<.001) 0.36 (<.001) 0.41 (<.001) 0.27 (.002) 0.34 (<.001) 0.27 (.004) 0.30 (.001) 0.35 (<.001) 0.23 (.011)
>$100,000 0.30 (.001) 0.28 (.002) 0.38 (<.001) 0.07 (.421) 0.25 (.005) 0.20 (.036) 0.26 (.005) 0.29 (.001) 0.23 (.010)
a

Referent group for family income level.

Discussion

This was the largest known study of its kind to examine associations of child demographic variables with QOL in children with advanced cancer. While other studies have limited recruitment to a new cancer diagnosis, a specific cancer type, and/or one health system (Bilodeau et al., 2018; Bona et al., 2015, 2016; Dupuis et al., 2016; Ilowite et al., 2018; Phipps et al., 2002; Rosenberg et al., 2016), this unique dataset represented children across the United States with any type of relapsed or refractory cancer. This distinguishes our study from the PediQuest study, which was limited to children receiving care at three coastal, urban medical centers (Rosenberg et al., 2016).

Results demonstrated a statistically significant impact of younger age on the adjusted total and anxiety (procedural and treatment) scale scores, similar to the few studies that have previously explored and published correlations between child age and QOL (Dupuis et al., 2016; Sitaresmi et al., 2008). The effect sizes in our study were smaller than those noted in the Dupuis et al. (2016) study. The difference in effect size between the studies may be attributed to the difference in the ages included in each sample (2–9.9 years (Dupuis et al., 2016) and 2–18 years (Sitaresmi et al., 2008) compared to 7–18 years in our study). Another potential explanation for the difference in effect size is the difference between the proxy parental report used for the younger age groups in Dupuis et al. (2016) and Sitaresmi et al. (2008) compared to our study that only used child self-report. Although previously reported correlations between the patient (r = 0.89) and parent (r = 0.81) report are high, some studies have found that parents may over-report children's symptoms (Lawitschka et al., 2014; Parsons et al., 2012; Waters et al., 2003).

Gender differences did not impact QOL, which is consistent with other studies that have explored QOL in children with ALL using the PedsQL instrument (Dupuis et al., 2016; Rosenberg et al., 2016; Sitaresmi et al., 2008). However, in a similar sample of 104 children with advanced cancer aged 2–17 years, female gender (2.28 (95% CI 0.14–4.42), p = .04) was associated with higher symptom burden using the Memorial Symptom Assessment Scale (Wolfe et al., 2015). Other correlates of symptom burden were diagnosis of a brain tumor, recent disease progression, and recent moderate-to-high-intensity chemotherapy (Wolfe et al., 2015). Additional research is needed to determine whether gender has an agnostic effect on QOL and the relationship between symptom burden and gender.

The findings of this study suggested that lower family income was correlated with poorer child QOL. The proportion of low-income participants (<$25,000 annually) in this study was 39.1%, which is greater than the reported national average of 19.2% (Semega et al., 2020). The impact of financial hardship and toxicity has been well described, and lower income has been associated with poorer outcomes, including increased incidence of graft versus host disease (GVHD) following allogeneic transplant (Bilodeau et al., 2018; Bona et al., 2015). Parents of children with cancer report living paycheck to paycheck and decreasing contributions to retirement, insurance, and college funds to pay for healthcare expenses (Bilodeau et al., 2018; Bona et al., 2015). This is one of the largest known studies to note a statistically significant correlation between income and total and scale PedsQL, supporting the findings of Ilowite et al. (2018).

This secondary analysis was limited by the cross-sectional design. It is unknown if families suffered financial toxicity due to childhood cancer or were already in low socioeconomic brackets pre-cancer, which may have influenced child QOL. Future studies should assess for change in socioeconomic status over time and evaluate the impact of this change. Low-income participants are over-represented in this sample compared to the national average, which could have been due in part to selection bias due to financial incentives. There is a sampling threat created by convenience sampling of enrollment after interaction with a Facebook advertisement. Future research should explore factors that motivate enrollment for clinical studies through social media platforms. Finally, this study was limited to child and parent self-reports. Therefore, the means of assessing family income was subjective rather than an objective source such as tax returns.

This study emphasizes the importance of assessing financial hardship and appreciating the impact age and financial status has on the QOL in children with advanced cancers. Oncology nurses should screen pediatric patients to identify families who may benefit from additional resources and supportive care to promote QOL. Future research could tailor QOL interventions to low-income families and young children as these families may be more likely to benefit.

Acknowledgments

The authors acknowledge additional R01 study team members, including Drs Mary Jo Gilmer and Debra L. Friedman (Co-Investigators); Drs Pamela S. Hinds, Verna Hendricks-Ferguson, Barbara Given, and Cynthia Gerhardt (Consultants); and Ms Sarah Wray (Study Coordinator).

Author Biographies

Piera C. Robson, PhD(c), CNS, NP, AOCNS, ANP-BC, OCN, CRN is a doctoral student at Vanderbilt University in Nashville, TN in their PhD in Nursing Science program.

Mary S. Dietrich, PhD, MS is a Professor of Statistics and Measurement at Vanderbilt University School of Medicine and School of Nursing in Nashville, TN.

Terrah Foster Akard, PhD, RN, CPNP, FAAN an Associate Professor of Nursing and Medicine and Director of Graduate Studies, PhD in Nursing Science at Vanderbilt University, Nashville, TN.

Footnotes

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institute of Nursing Research (grant RO1 NR015353; ClinicalTrials.gov number NCT04059393; principal investigator: T.F.A.) and NIH/National Center for Advancing Translational Sciences (grant UL1 TR000445). Additionally, this project was conducted in collaboration with the Palliative Care Research Cooperative Group funded by the National Institute of Nursing Research (grant U24 NR014637).

ORCID iD: Piera C. Robson https://orcid.org/0000-0001-7185-7915

References

  1. Abel G. A., Albelda R., Khera N., Hahn T., Salas Coronado D. Y., Odejide O. O., Bona K., Tucker-Seeley R., Soiffer R. (2016). Financial hardship and patient-reported outcomes after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 22(8), 1504-1510. 10.1016/j.bbmt.2016.05.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avoine-Blondin J., Parent V., Fasse L., Lopez C., Humbert N., Duval M., Sultan S. (2018). How do professionals assess the quality of life of children with advanced cancer receiving palliative care, and what are their recommendations for improvement? BMC Palliative Care, 17(1), 71. 10.1186/s12904-018-0328-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akard T. F., Dietrich M. S., Friedman D. L., Hinds P. S., Given B., Wray S., Gilmer M. J. (2015). Digital storytelling: an innovative legacy-making intervention for children with cancer. Pediatric Blood and Cancer, 62(4), 658-665. 10.1002/pbc.25337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Akard T. F., Duffy M., Hord A., Randall A., Sanders A., Adelstein K., Anani U. E., Gilmer M. J. (2018). Bereaved mothers’ and fathers’ perceptions of a legacy intervention for parents of infants in the NICU. Journal of Neonatal-Perinatal Medicine, 11(1), 21-28. 10.3233/NPM-181732 [DOI] [PubMed] [Google Scholar]
  5. Akard T. F., Wray S., Friedman D. L., Dietrich M. S., Hendricks-Ferguson V., Given B., Gerhardt C. A., Hinds P. S., Gilmer M. J. (2020). Transforming a face-to-face legacy intervention to a web-based legacy intervention for children with advanced cancer. Journal of Hospice & Palliative Nursing, 22(1), 49-60. 10.1097/NJH.0000000000000614 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bilodeau M., Dussel V., Wolfe J. (2019). Experience of parents receiving results from a quality-of-life study in pediatric advanced cancer: A report from the PediQUEST study. Pediatric Blood and Cancer, 66(9), e27880. 10.1002/pbc.27880 [DOI] [PubMed] [Google Scholar]
  7. Bilodeau M., Ma C., Al-Sayegh H., Wolfe J., Bona K. (2018). Household material hardship in families of children post-chemotherapy. Pediatric Blood and Cancer, 65(1), 1-4. 10.1002/pbc.26743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bona K., London W. B., Guo D., Abel G., Lehmann L., Wolfe J. (2015). Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biology of Blood Marrow Transplantation, 21(2), 312-318. 10.1016/j.bbmt.2014.10.016 [DOI] [PubMed] [Google Scholar]
  9. Bona K., London W. B., Guo D., Frank D. A., Wolfe J. (2016). Trajectory of material hardship and income poverty in families of children undergoing chemotherapy: A prospective cohort study. Pediatric Blood and Cancer, 63(1), 105-111. 10.1002/pbc.25762 [DOI] [PubMed] [Google Scholar]
  10. Dupuis L. L., Lu X., Mitchell H. R., Sung L., Devidas M., Mattano L. A., Jr., Carroll W. L., Winick N., Hunger S. P., Maloney K. W., Kadan-Lottick N. S. (2016). Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children’s Oncology Group. Cancer, 122(7), 1116-1125. 10.1002/cncr.29876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eiser C., Stride C. B., Vora A., Goulden N., Mitchell C., Buck G., Adams M., Jenney M. E. M., National Cancer Research Institute Childhood Leukaemia, S.-G., & Network, U. K. C. L. C. (2017). Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study. Pediatric Blood and Cancer, 64(11), 1–8. 10.1002/pbc.26615 [DOI] [PubMed] [Google Scholar]
  12. Harris P. A., Taylor R., Minor B. L., Elliott V., Fernandez M., O'Neal L., McLeod L., Delacqua G., Delacqua F., Kirby J., Duda S. N., Consortium R. E. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95(2019), 103208,, 1-10. 10.1016/j.jbi.2019.103208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harris P. A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J. G. (2009). Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377-381. 10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Howell D., Molloy S., Wilkinson K., Green E., Orchard K., Wang K., Liberty J. (2015). Patient-reported outcomes in routine cancer clinical practice: A scoping review of use, impact on health outcomes, and implementation factors. Annals of Oncology, 26(9), 1846-1858. 10.1093/annonc/mdv181 [DOI] [PubMed] [Google Scholar]
  15. Ilowite M. F., Al-Sayegh H., Ma C., Dussel V., Rosenberg A. R., Feudtner C., Kang T. I., Wolfe J., Bona K. (2018). The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. Cancer, 124(19), 3934-3941. 10.1002/cncr.31668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lawitschka A., Guclu E. D., Varni J. W., Putz M., Wolff D., Pavletic S., Greinix H., Peters C., Felder-Puig R. (2014). Health-related quality of life in pediatric patients after allogeneic SCT: Development of the PedsQL Stem Cell Transplant module and results of a pilot study. Bone Marrow Transplantation, 49(8), 1093-1097. 10.1038/bmt.2014.96 [DOI] [PubMed] [Google Scholar]
  17. Macpherson C. F., Johnson R. H., Landwehr M. S., Watson S. E., Stegenga K. (2020). “Aftermath”: Financial resource requirements of young adults moving forward after cancer treatment. Journal of Adolescent and Young Adult Oncology, 9(3), 354–358. 10.1089/jayao.2019.0120 [DOI] [PubMed] [Google Scholar]
  18. McCullough A., Ruehrdanz A., Jenkins M. A., Gilmer M. J., Olson J., Pawar A., Holley L., Sierra-Rivera S., Linder D. E., Pichette D., Grossman N. J., Hellman C., Guerin N. A., O'Haire M. E. (2018). Measuring the effects of an animal-assisted intervention for pediatric oncology patients and their parents: A multisite randomized controlled trial. Journal of Pediatric Oncology Nursing, 35(3), 159-177. 10.1177/1043454217748586 [DOI] [PubMed] [Google Scholar]
  19. Parsons S. K., Fairclough D. L., Wang J., Hinds P. S. (2012). Comparing longitudinal assessments of quality of life by patient and parent in newly diagnosed children with cancer: The value of both raters’ perspectives. Quality of Life Research, 21(5), 915-923. 10.1007/s11136-011-9986-4 [DOI] [PubMed] [Google Scholar]
  20. Phipps S., Dunavant M., Lensing S., Rai S. N. (2002). Acute health-related quality of life in children undergoing stem cell transplant: II. Medical and demographic determinants. Bone Marrow Transplantation, 29(5), 435-442. 10.1038/sj.bmt.1703376 [DOI] [PubMed] [Google Scholar]
  21. Rae C., Furlong W., Feeny D., Couchman R., Silverman L., Sallan S., Laverdiere C., Clavell L., Michon B., Kelly K., Larsen E., Pullenayegum E., Athale U., Barr R. (2018). Health status and health-related quality of life measurement in pediatric cancer clinical trials: An examination of the DFCI 00-01 acute lymphoblastic leukemia protocol. Journal of Pediatric Hematology/Oncology, 40(8), 580-587. 10.1097/MPH.0000000000001235 [DOI] [PubMed] [Google Scholar]
  22. Rosenberg A. R., Orellana L., Ullrich C., Kang T., Geyer J. R., Feudtner C., Dussel V., Wolfe J. (2016). Quality of life in children with advanced cancer: A report from the PediQUEST study. Journal of Pain and Symptom Management, 52(2), 243-253. 10.1016/j.jpainsymman.2016.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Santacroce S. J., Kneipp S. M. (2019). A conceptual model of financial toxicity in pediatric oncology. Journal of Pediatric Oncology Nursing, 36(1), 6-16. 10.1177/1043454218810137 [DOI] [PubMed] [Google Scholar]
  24. Semega J., Kollar M., Creamer J., Mohanty A. (2020). Income and poverty in the United States: 2018 current population reports . Retrieved August 12, 2020, from https://www.census.gov/content/dam/Census/library/publications/2019/demo/p60-266.pdf
  25. Sitaresmi M. N., Mostert S., Gundy C. M., Sutaryo, Veerman A. J. (2008). Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health and Quality of Life Outcomes, 6(96), 1-8. 10.1186/1477-7525-6-96 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith A. W., Parsons H. M., Kent E. E., Bellizzi K., Zebrack B. J., Keel G., Lynch C. F., Rubenstein M. B., Keegan T. H., & Group, A. H. S. C. (2013). Unmet support service needs and health-related quality of life among adolescents and young adults with cancer: The AYA HOPE study. Frontiera in Oncology, 3(article 75), 1-11. 10.3389/fonc.2013.00075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ullrich C. K., Dussel V., Orellana L., Kang T. I., Rosenberg A. R., Feudtner C., Wolfe J. (2018). Self-reported fatigue in children with advanced cancer: Results of the PediQUEST study. Cancer, 124(18), 3776-3783. 10.1002/cncr.31639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Varni J. W. (2017). Scaling and scoring of the Pediatric Quality of Life Inventory PedsQL . Retrieved August 11, 2020, from https://www.pedsql.org/PedsQL-Scoring.pdf
  29. Varni J. W., Burwinkle T. M., Katz E. R., Meeske K., Dickinson P. (2002). The PedsQL in pediatric cancer: Reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer, 94(7), 2090-2106. 10.1002/cncr.10428 [DOI] [PubMed] [Google Scholar]
  30. Varni J. W., Burwinkle T. M., Seid M. (2005). The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children. Expert Review of Pharmacoeconomics & Outcomes Research, 5(6), 705-719. 10.1586/14737167.5.6.705 [DOI] [PubMed] [Google Scholar]
  31. Varni J. W., Limbers C., Burwinkle T. M. (2007). Literature review: Health-related quality of life measurement in pediatric oncology: hearing the voices of the children. Journal of Pediatric Psychology, 32(9), 1151-1163. 10.1093/jpepsy/jsm008 [DOI] [PubMed] [Google Scholar]
  32. Waters E. B., Wake M. A., Hesketh K. D., Ashley D. M., Smibert E. (2003). Health-related quality of life of children with acute lymphoblastic leukaemia: Comparisons and correlations between parent and clinician reports. International Journal of Cancer, 103(4), 514-518. 10.1002/ijc.10815 [DOI] [PubMed] [Google Scholar]
  33. Wolfe J., Orellana L., Cook E. F., Ullrich C., Kang T., Geyer J. R., Feudtner C., Weeks J. C., Dussel V. (2014). Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. Journal of Clinical Oncology, 32(11), 1119-1126. 10.1200/JCO.2013.51.5981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wolfe J., Orellana L., Ullrich C., Cook E. F., Kang T. I., Rosenberg A., Geyer R., Feudtner C., Dussel V. (2015). Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST study. Journal of Clinical Oncology, 33(17), 1928-1935. 10.1200/JCO.2014.59.1222 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Pediatric Oncology Nursing are provided here courtesy of SAGE Publications

RESOURCES